
Fina Biotech (Fina) is a biotechnology company. The company selects, finances, conducts, develops and sells biotechnology projects. It offers in vitro diagnostic product Halosperm, which is a kit to determine the degree of DNA fragmentation in human sperm, using sperm chromatin dispersion (SCD) technique. It produces new tools for monitoring, diagnosis, prognosis and treatment of significant diseases. Fina investments in the areas of oncology, cardiology and stem cell therapy. The companys diagnostics areas include bladder cancer, restenosis, bio energetic signature, prostate cancer, colon cancer, deep vein thromobos, myocardial infarction, and brain stroke. It partners with halotech, SF biotech, abg patentes, HERRERO & ASOCIADOS, and others. Fina is headquartered in Madrid, Spain.